Related references
Note: Only part of the references are listed.Early Prostate Cancer Antigen-2: A Controversial Prostate Cancer Biomarker?
Eleftherios P. Diamandis
CLINICAL CHEMISTRY (2010)
Peptides Generated Ex Vivo from Serum Proteins by Tumor-Specific Exopeptidases Are Not Useful Biomarkers in Ovarian Cancer
John F. Timms et al.
CLINICAL CHEMISTRY (2010)
National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for Use of Tumor Markers in Liver, Bladder, Cervical, and Gastric Cancers
Catharine M. Sturgeon et al.
CLINICAL CHEMISTRY (2010)
Next-Generation Sequencing: A New Revolution in Molecular Diagnostics?
Eleftherios P. Diamandis et al.
CLINICAL CHEMISTRY (2009)
Markers of dispute
Virginia Hughes
NATURE MEDICINE (2009)
Screening for Prostate Cancer - The Controversy That Refuses to Die
Michael J. Barry
NEW ENGLAND JOURNAL OF MEDICINE (2009)
被撤回的出版物: Analysis of a Serum Test for Prostate Cancer That Detects a Second Epitope of EPCA-2 (Retracted article. See vol. 72, pg. 1157, 2012)
Eddy S. Leman et al.
PROSTATE (2009)
Ovarian Cancer Early Detection Claims Are Biased
Martin McIntosh et al.
CLINICAL CANCER RESEARCH (2008)
Diagnostic markers for early detection of ovarian cancer
Irene Visintin et al.
CLINICAL CANCER RESEARCH (2008)
National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for the Use of Tumor Markers
Eleftherios P. Diamandis et al.
CLINICAL CHEMISTRY (2008)
National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for Use of Tumor Markers in Testicular, Prostate, Colorectal, Breast, and Ovarian Cancers
Catharine M. Sturgeon et al.
CLINICAL CHEMISTRY (2008)
National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for Use of Tumor Markers in Clinical Practice: Quality Requirements
Catharine M. Sturgeon et al.
CLINICAL CHEMISTRY (2008)
Pivotal Evaluation of the Accuracy of a Biomarker Used for Classification or Prediction: Standards for Study Design
Margaret S. Pepe et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2008)
SELDI-TOF MS whole serum proteomic profiling with IMAC surface does not reliably detect prostate cancer
Dale McLerran et al.
CLINICAL CHEMISTRY (2008)
POINT: EPCA-2: A promising new serum biomarker for prostatic carcinoma?
Eleftherios P. Diamandis
CLINICAL BIOCHEMISTRY (2007)
被撤回的出版物: Initial analyses of colon cancer-specific antigen (CCSA)-3 and CCSA-4 as colorectal cancer-associated serum markers (Retracted article. See vol. 73, pg. 1034, 2013)
Eddy S. Leman et al.
CANCER RESEARCH (2007)
EPCA-2: A highly specific serum marker for prostate cancer
Eddy S. Leman et al.
UROLOGY (2007)
Differential exoprotease activities confer tumor-specific serum peptidome patterns
J Villanueva et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Selective reporting biases in cancer prognostic factor studies
PA Kyzas et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2005)
Serum protein markers for early detection of ovarian cancer
G Mor et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Prediction of cancer outcome with microarrays: a multiple random validation strategy
S Michiels et al.
LANCET (2005)
Opinion - Bias as a threat to the validity of cancer molecular-marker research
DF Ransohoff
NATURE REVIEWS CANCER (2005)
Mass Spectrometry as a diagnostic and a cancer biomarker discovery tool - Opportunities and potential limitations
EP Diamandis
MOLECULAR & CELLULAR PROTEOMICS (2004)
Towards complete and accurate reporting of studies of diagnostic accuracy: The STARD initiative
PM Bossuyt et al.
CLINICAL CHEMISTRY (2003)
Plasma lysophosphatidic acid concentration and ovarian cancer
DL Baker et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2002)
Osteopontin as a potential diagnostic biomarker for ovarian cancer
JH Kim et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2002)
Use of proteomic patterns in serum to identify ovarian cancer
EF Petricoin et al.
LANCET (2002)
Share Paper
